Rationale: Neovascularization stimulated by local or recruited stem cells after ischemia is a key process that salvages damaged tissue and shows similarities with embryonic vascularization. Apelin receptor (Aplnr) and its endogenous ligand apelin play an important role in cardiovascular development. However, the role of apelin signaling in stem cell recruitment after ischemia is unknown.
S everal studies have reported the existence of circulating progenitor/stem cells originating from the bone marrow (BM). These circulating cells play a central role in postembryonic vasculogenesis, in analogy to angioblasts during embryonic development. 1 Several reports have shown that in animal models of ischemia, progenitor/stem cells are mobilized and recruited to sites of ischemic neovascularization, including hind limb ischemia and myocardial infarction (MI), where they enhance the formation of new blood vessels by paracrine release of chemokines and angiotrophic factors and differentiation into endothelial cells. [2] [3] [4] Together with the observation that bone marrow-derived progenitor/stem cell numbers are increased in patients after an acute MI, 5, 6 this suggests that these cells may play an essential role in the repair response mechanism after ischemia. The therapeutic potential of these cells in tissue preservation and/or regeneration after ischemia has also been demonstrated by several studies in which incorporation of these stem cells into the ischemic heart improved capillary density and residual contractile function. [7] [8] [9] Additionally, several molecular mediators of the ischemic repair response, including vascular endothelial growth factor (VEGF), granulocyte-macrophage colony-stimulating factor (GM-CSF), stromal cell-derived factor (SDF-1), and angiopoietin-1 (Ang-1), were shown to enhance the recruitment of circulating progenitor/stem cells and neovascularization in ischemic tissue. 10 -13 and some have already been used in clinical studies. 14 Although the effectiveness of stem cell mobilization shows great promise for therapy, 15 the process has proven to be extremely complex involving several cell subtypes and molecular signals that are not explained by the current identified mediators. Further characterization of the biology of these cells and the molecular mechanism that activates and recruits them is needed to design new therapeutic strategies.
Recently, we performed a genome-wide expression profile study in order to identify new genes involved in the regulation of vasculogenesis. Gene expression profiles of isolated angioblasts during early murine development were compared with the nonangioblast cells. Apelin receptor (Aplnr) was specifically expressed in angioblasts in the early phase of embryogenesis, which suggests a potential regulatory role in vasculogenesis in development. 16 Aplnr, a member of the G-protein-coupled receptor family, and apelin, its natural ligand, are highly expressed in the cardiovascular system during development and adulthood. 17, 18 Loss of apelin or Aplnr in zebrafish and xenopus larvae resulted in defective intersomitic vessel formation and cardiac development during embryogenesis. 19 -21 Apelin signaling has been shown to be involved in the regulation of blood pressure, 22, 23 cardiac contractility, 24, 25 and cardiac differentiation. 26, 27 In addition, apelin/Aplnr signaling is associated with retinal blood vessel formation and tumor angiogenesis. 17, 28, 29 The marked upregulation of both apelin and Aplnr after hypoxic insult in adult animals 30, 31 also suggest a role in ischemia-driven vasculogenesis.
Beneficial effects of apelin administration after MI have been reported previously, 32, 33 but this was performed in ischemia-reperfusion models and attributed to the direct cardioprotective actions involving the RISK pathway. A direct positive inotropic effect after MI has also been reported. 34 In the present study, we sought to test the hypothesis that apelin and Aplnr are important regulators in the early mobilization and recruitment of cKitϩ/Flk1ϩ cells, specifically after MI. For this purpose, we used a permanent ligation model to exclude an effect of apelin on ischemia-reperfusion damage. In the first days after MI, apelin was shown to enhance the recruitment of specifically cKitϩ/Flk1ϩ/Aplnrϩ cells into the heart after MI. Apelin-recruited Aplnrϩ cells were shown to improve myocardial neovascularization by a paracrine function and not by transdifferentiation. The presence of recruited cKitϩ/Flk1ϩ/Aplnrϩ cells after MI promoted a local proangiogenic cytokine profile, which resulted in neovascularization, less adverse remodeling, and subsequent preservation of cardiac function after MI.
Methods
This study was performed in accordance with the Council of Europe Convention (ETS123)/Directive (86/609/EEC) for the protection of vertebrate animals used for experimental and other scientific purposes and with the approval of the National and local Animal Care Committee.
Animals
Eight-week-old female C57BL/6-Tg(CAG-EGFP)1Osb/J mice (Jackson laboratories, Bar Harbor, ME). These mice express EGFP under the control of a chicken ␤-actin promoter and cytomegalovirus enhancer in all cells. Wild-type female C57BL/6J mice (age, 8 weeks) were obtained from Jackson laboratories and randomly assigned to the experimental groups.
In Vitro Viral Transduction of Donor Bone Marrow Cells
C57BL/6-Tg(CAG-EGFP)1Osb/J donors were euthanized by cervical dislocation and tibias and femurs were harvested and flushed with PBS to retrieve bone marrow. Single cell suspensions were transduced with sh.Aplnr or sh.sham (moiϭ15). After 48 hours of incubation, Aplnr protein and mRNA expression were verified by quantitative PCR and Western blot analysis as described below.
Bone Marrow Transplantation
C57BL/6 recipients were irradiated (2ϫ4.5 Gy) and injected intravenously with 2.5ϫ10 6 bone marrow cells, transduced with either sh.Aplnr, sh.sham, or EGFP as described.
The recipient mice were allowed to recover for 4 weeks under sterile conditions. The efficiency of BM repopulation was verified by flow cytometric analysis (BD FACSCanto, BD Biosciences, Erembodegem, Belgium) of EGFP expression in circulating and BM aspirate cells. BM functionality after transplantation was assessed using a Hemavet Mascot Multispecies Hematology System Counter 1500R (CDC Technology, Oxford, United Kingdom).
Surgical Procedures
Mice (age, 12 weeks) were weighed, sedated with 4% isoflurane, intubated, and pressure-control ventilated with O 2 -N 2 (1:2, vol/vol) containing Ϸ2.5% isoflurane for anesthesia. MI was induced by permanent ligation of the left anterior descending coronary artery, as described before, 35 with a 7-0 silk suture (BBraun, Aesculap AG&CO.KG, Tuttlingen, Germany). Hind limb ischemia (HLI) was induced by a permanent ligation of the femoral artery with a 6-0 silk suture (BBraun). Sham animals were subjected to the operation without arterial ligation. Every day for 5 days, animals were euthanized and tissues were harvested for subsequent analysis.
The mice were injected in the ischemic gastrocnemic muscle or myocardium with either 8 ng apelin-13 (Sigma) in 10 L saline, or with saline only. Every day for 5 days, animals were euthanized and tissues were harvested for analysis. In a different set of animals, we intravenously injected VEGFA, SDF␣, apelin (all with a concentration of 8 ng/10 L), or saline to study the effect on mobilization between the subsets.
Non-standard Abbreviations and Acronyms
To further assess the function of apelin/Aplnr signaling after myocardial ischemia, bone marrow from C57BL/6-Tg(CAG-EGFP)1Osb/J was harvested and infected by sh.sham or sh.Aplnr, as described above and subsequently transplanted into irradiated C57BL/6J wt mice. After the induction of MI, transplanted animals received either an intramyocardial injection of 8 ng apelin in 10 L saline, saline, only or no injection. Animals were euthanized at 2, 6, or 14 days after MI. At 2 days, the animals were euthanized and the recruitment of cKitϩ/Flk1ϩ cells into heart was assessed by flow cytometry. At 5 days, the local production of angiogenic cytokines in the infarcted hearts was assessed. Other animals were used to isolated cKitϩ/Flk1ϩ/Aplnrϩ cells from the heart to study if these cells were producing angiogenic growth factors. At 14 days after MI, hemodynamic measurements were performed under general anesthesia, as described before. 35 In brief, shortand long-axis view M-mode LV echocardiography (ALOKA, Prosound SSD-4000; Tokyo, Japan) was performed by a single blinded observer. From these images left ventricular end-diastolic (LVEDD) and end-systolic (LVESD) diameter were quantified, and fractional shortening calculated (FSϭLVEDDϪLVESD/ LVEDDϫ100%) by 2 independent blinded observers.
In a subset of animals a 1.4F microtipped pressure transducer catheter (Millar Instruments, Houston, TX) was inserted into the LV. All data were recorded, digitized, and analyzed with a software program written in Matlab for determination of maximum rate of rise of LV pressure (LVdP/dt max ) and maximum rate of fall of LV pressure (LVdP/dt min ).
Left ventricular weight including septum and lung fluid weight were determined as surrogate markers for LV hypertrophy and manifest heart failure. Tibia length was used as a measure of age/growth of the mouse.
Flow Cytometric Analysis
Mononuclear cell suspensions of BM and blood were obtained by Ficoll density centrifugation and subsequent washing in RPMImedium. Single cell suspensions of ventricles and gastrocnemic muscles were isolated by homogenization, washing, and filtration over a 40-m Falcon cell strainer. Isolated cells were incubated with antibodies against Flk1 (Biotin-conjugated, BD Biosciences), cKit (APC-Cy7-conjugated, eBiosciences, Hatfield, United Kingdom), Sca1 (APC-conjugated, eBiosciences), Ter119, B220, CD11b, Gr-1, CD3, CD4, CD8 (PE-conjugated, eBiosciences), and Aplnr (LifeSpan Biosciences, Seattle, WA) for 15 minutes at 4°C. After washing, cells were incubated with goat anti-rabbit antibodies labeled with Alexa 488 (Invitrogen) and streptavidin (PeCy7-conjugated, eBiosciences) for 15 minutes at 4°C. 7AAD (BD biosciences) was used to select for cell viability. Flow cytometric analysis was performed on a FACSCanto (BD Biosciences) and subsequent data analysis by use of Flowjo software (Tree Star Inc, Ashland, OR). Reported values were normalized to naive control values, which were arbitrarily assigned the average value of 100. Using the same approach, cell sorting was performed on a FACSAria (BD Biosciences).
Histological Analysis
The left ventricles were embedded in paraffin and cut longitudinally into 5-m sections and stained with standard hematoxylin and eosin and Masson trichrome to determine infarct size and cardiomyocyte cross-sectional area. To assess capillary density in the infarct borderzone, sections were also stained using isolectin. Briefly, sections were rehydrated and incubated with HRP-conjugated GS lectin (Sigma) in 5% BSA/PBS for 90 minutes at RT. Sections were washed in PBS and incubated for 5 minutes with NiDAB. Arteriolar density was assessed by staining with alkaline phosphataseconjugated antibody against smooth muscle cell ␣-actin in 5% BSA/PBS for 90 minutes at RT. Sections were washed in PBS and incubated for 5 minutes with BCIP/NBT Alkaline Phosphatase Substrate (Vector Laboratories, Burlingame, CA).
After washing, sections are counterstained with nuclear fast red, dehydrated, and cover-slipped with Entellan (MERCK, Darmstadt, Germany). Data analysis was performed using a commercial image analysis system (Impak C, Clemex Technologies, Quebec, Canada).
For an extensive description of materials and methods, see the Online Data Supplement.
Statistical Analysis
Data were analyzed by 1-way or 2-way ANOVA, as appropriate, followed by individual unpaired Student t tests. Significance was accepted at a level of PϽ0.05. All data are presented as meanϮSEM, unless otherwise stated.
Results

Aplnr Expression on Circulating Cells and Apelin Expression After Ischemia
To investigate the role of Aplnr and apelin in cell recruitment, Aplnr expression was assessed in different cell populations from the circulation by flow cytometry and quantitative PCR. Aplnr was highly expressed in all cKitϩ/Flk1ϩ circulating cells, showing a 9-fold higher mRNA expression and a 15-fold higher protein expression of Aplnr when compared with other circulating cell populations ( Figure 1A through 1C). Serum levels of apelin were increased during the first 2 days after MI and gradually lowered during the following days. However, apelin levels failed to rise after HLI ( Figure  1H ). Myocardial apelin mRNA and protein expression were upregulated in the early days after the induction of MI, as compared with sham-operated animals ( Figure 1D and 1F). In contrast, no increase of apelin mRNA or protein was noted in ischemic skeletal muscle after HLI ( Figure 1E and 1G). These data suggest a possible role for Aplnr and apelin in the recruitment of the cKitϩ/Flk1ϩ cells specifically after MI.
Cell Recruitment After Ischemia
To test if cKitϩ/Flk1ϩ cells were indeed specifically recruited to the infarcted heart, cell subsets were assessed by flow cytometry 3 days after the induction of MI and HLI. After HLI, Sca1ϩ/Flk1ϩ cells but not cKitϩ/Flk1ϩ cells were increased 1.9-fold in the skeletal muscle and 1.7-fold in the circulation, when compared with control and shamoperated animals ( Figure 2D , 2F, 2J, and 2L). However, this subset was not recruited to the myocardium and/or the circulation after myocardial ischemia ( Figure 2J and 2K). The cKitϩ/Flk1ϩ cells showed opposite effects. After MI, cKitϩ/Flk1ϩcells but not Sca1ϩ/Flk1ϩcells were increased by 2.1-fold in the myocardium as well as in the circulation compared with sham-operated animals and control animals ( Figure 2D and 2E) but failed to respond to HLI ( Figure 2F ). As Aplnr was predominantly expressed in the cKitϩ/Flk1ϩ cell population, these findings point to a possible involvement of Aplnr/apelin signaling in this myocardial-specific repair response after ischemia. Interestingly, these cells were preferentially recruited to the borderzone of the infarct and not to other regions of the heart (Online Figure I ).
Apelin Promotes Mobilization and Recruitment of cKit؉/Flk1؉ Cells
To investigate if apelin is capable of mobilizing and recruiting cKitϩ/Flk1ϩ cells, C57BL/6J mice received a single injection of apelin or saline in the ischemic myocardium or gastrocnemic muscle. During the following days, animals were euthanized and blood and tissues were analyzed for recruited cKitϩ/Flk1ϩ cells using flow cytometry. Apelin injection after MI resulted in an accelerated mobilization of cKitϩ/Flk1ϩ cells into the circulation, as compared with saline-injected or noninjected animals ( Figure 3A ). After apelin injection, cKitϩ/Flk1ϩ cell numbers were already enhanced from day 1 on and the peak values were reached at day 2, whereas in saline-injected or noninjected animals a , and striated muscle (C). cKitϩ/Flk1ϩ cells were mobilized into blood and recruited to the myocardium 3 days after MI. D, E, and F, Quantification of cKitϩ/Flk1ϩ cells in blood (D), myocardium (E), and striated muscle (F) (nϭ8 per group). G, H, and I, Representative flow cytometry data of blood (G), heart (H), and striated muscle (I) for Sca1ϩ/ Flk1ϩ cells. Sca1ϩ/Flk1ϩ cell numbers were specifically increased in the circulation and striated muscle after hind limb ischemia. J, K, and L, Quantification of Sca1ϩ/Flk-1ϩ cells in blood (J), myocardium (K), and striated muscle (L) (nϭ8 per group). *PϽ0.05 versus naive animals. similar peak level was reached after 3 days. After apelin injection, an increase of 54% in mobilized cKitϩ/Flk1ϩ cells in the circulation was noted at day 2 when compared with saline-injected or noninjected animals ( Figure 3B and 3E) . Intramyocardial injections of apelin increased infiltrating cKitϩ/Flk1ϩ cells by 52% when compared with salineinjected animals ( Figure 3C and 3F) . Likewise, cKitϩ/Flk1ϩ cells in gastrocnemic muscle increased after local apelin injection, although this was not statistically significant (Pϭ0.071) when compared with controls ( Figure 3D and 3G). Interestingly, Scaϩ/Flk1ϩ cells seem not responsive to apelin, whereas VEGFA and SDF␣ were able to mobilize these cells to the circulation (Online Figure II) . However, whereas apelin could induce a mobilization response of the cKitϩ/Flk1ϩ cells, VEGFA and SDF␣ seem to have no effect on the mobilization of these cells. These data suggest that apelin functions in addition to VEGFA and SDF␣ by selectively promoting mobilization of cKitϩ/Flk1ϩ cells but not the Sca1ϩ/Flk1ϩ cells to the circulation and promotes recruitment into ischemic tissue.
Apelin Recruits cKit؉/Flk1؉/Aplnr؉ Cells Into the Ischemic Heart After MI
To assess the effect of apelin-recruited cKitϩ/Flk1ϩ cells to the ischemic myocardium, unfractionated BM was harvested from C57BL/6-Tg(CAG-EGFP)1Osb/J mice. This BM, which ubiquitously expresses EGFP, was infected with a lentivirus encoding a shRNA targeting Aplnr (sh.Aplnr) or sham lentivirus, encoding nontargeting scrambled shRNA (sh.sham). Infected BM cells were subsequently transplanted into irradiated C57BL/6J wild-type recipients. Aplnr mRNA expression was decreased by 73% and protein expression was decreased by 71% in BM cells treated with sh.Aplnr, compared with controls ( Figure 4A and 4B) . After a repopulation period of 8 weeks, MI was induced and subsequently the animals either received an intramyocardial injection with apelin or saline into the infarcted heart, or no injection was given. To assess the effect of the Aplnr knockdown on the recruitment of cKitϩ/Flk1ϩ cells, animals were euthanized 2 days after the induction of MI. In sham-silenced animals, apelin injection resulted in an increase of cKitϩ/Flk1ϩ cell numbers ( Figure 4C ). Sca1ϩ/Flk1ϩ and Linϩ cell numbers did not change after apelin injection in sham-silenced animals ( Figure 4G and 4H ). Aplnr knockdown in BM cells resulted in a failure to recruit cKitϩ/Flk1ϩ cells into the myocardium after MI ( Figure 4D ). Sca1ϩ/Flk1ϩ and Linϩ cell numbers did not differ between sh.sham-and sh.Aplnr-treated animals ( Figure 4G and 4H) , showing that endogenous apelin does not recruit these cells into the myocardium after a MI. Accordingly, in these animals, apelin injection with Aplnr-silenced BM failed to induce recruitment of cKitϩ/Flk1ϩ cells into the ischemic heart ( Figure 4D ).
Apelin Recruitment of Aplnr؉ Cells Preserves Left Ventricular Function After MI
Next, we assessed the effects of recruitment via Aplnr/apelin signaling after MI. As Aplnr has been shown to affect heart function via direct stimulation of cardiomyocytes and local ECs, we proceeded with the BM transplantation setup to exclude possible confounding effects. Four weeks after transplantation, BM transplant efficiency and functionality were assessed. Both transplantation groups showed that more than 99% cells from the BM and around 97% of the circulating cells were green fluorescent protein-positive (Online Figure  III) . The numbers WBCs, lymphocytes, neutrophils, and monocytes proved also to be not different between the 2 groups (Online Figure III) . To assess the effect of recruited cKitϩ/Flk1ϩ/Aplnrϩ cells on myocardial function after an infarct, another 78 BM hybrid animals were subjected to an MI and subsequently received an intramyocardial injection of either apelin or saline, or no injection was given. One day after induction, 36 animals were euthanized to assess infarct size using Evans blue dye. Initial infarct size was not different between all experimental groups (Online Figure IV) . At 2 weeks after MI, left ventricular remodeling and function were measured by echocardiography, including left ventricular end-diastolic diameter (EDD) and fractional shortening (FS). All animals showed an expected decrease in FS on comparison with historical sham-operated control animals (39Ϯ2%). 35 In sham-silenced animals, apelin injection resulted in a 48% improvement in FS, compared with saline-treated mice or control mice ( Figure 5A and 5D), whereas EDD was similar between these groups ( Figure 5C ). Aplnr-knockdown in the BM resulted in a significant reduction of FS by -41%, compared with their sham-silenced controls. In Aplnr-silenced animals, apelin failed to improve FS compared with saline-injected animals and noninjected animals ( Figure 5B and 5D) , providing clear evidence that the improved cardiac function can fully attributed to the recruited BM derived cells and not to confounding effects of Aplnr activation in cardiomyocytes and resident endothelial cells (ECs). In addition, in sham-silenced mice, left ventricular weight and lung fluid accumulation was reduced in apelintreated animals compared with control animals (Online Table  I ), suggesting an attenuation of myocardial hypertrophy with less pulmonary congestion. In contrast, Aplnr-knockdown animals without apelin treatment showed a trend toward an increase of left ventricular weight and lung fluid compared with their sham virus counterparts. Apelin injection failed to improve left ventricular and lung fluid weights in the Aplnrsilenced animals (Online Table I ).
A subset of animals was used to measure hemodynamic parameters, to assess cardiac function. In sham-silenced animals, apelin injection resulted in an significant increase of maximum rate of rise of LV pressure (LVdP/dt max ) and maximum rate of fall of LV pressure (LVdP/dt min ) compared with saline-treated mice (6596Ϯ367 mm Hg ⅐ s Ϫ1 versus 5654Ϯ265 mm Hg ⅐ s Ϫ1 and Ϫ6012Ϯ527 mm Hg ⅐ sϪ1 versus Ϫ5049Ϯ375 mm Hg ⅐ s Ϫ1 : nϭ6 per group; PϽ0.05). Aplnr-knockdown in the BM resulted in a significant reduction of LVdP/dt max and LVdP/dt min (4792Ϯ466 mm Hg ⅐ s Ϫ1 and Ϫ3898Ϯ515 mm Hg ⅐ s Ϫ1 : nϭ6 per group; PϽ0.05) as compared with saline-treated sh.sham animals. Apelin injection failed to improve these functional parameters (4920Ϯ247 mm Hg ⅐ s Ϫ1 and Ϫ3765Ϯ539 mm Hg ⅐ s Ϫ1 : nϭ6 per group; PϽ0.05).
Taken together, these findings indicate that the contractile function after MI was improved by a repair mechanism initiated by apelin, by recruitment of cKitϩ/Flk1ϩ/Aplnrϩ cells from the BM and circulation.
Aplnr؉ Cells Diminish Scar Formation After Myocardial Ischemia
The Aplnr-silenced BM recipients and control groups were further assessed on parameters of myocardial repair. Progressive left ventricular dysfunction after MI is caused by a combination of left ventricular dilation, compensatory cardiomyocyte hypertrophy, and scar formation. LV dilation was not attenuated by recruitment of cKitϩ/Flk1ϩ/Aplnrϩ cells after apelin treatment ( Figure 5C ). Myocyte cross-sectional area, as an indicator of cardiac hypertrophy, did not differ among the different groups at 14 days after MI ( Figure 6E ). However, apelin recruitment of Aplnrϩ cells resulted in a reduction in epicardial infarct length of 22% and an increase of infarct thickness of 47% when compared with sh.sham virus-treated controls (Figure 6C and 6D) . Silencing of endogenous Aplnr in the BM resulted in more extensive scar formation than their sham-silenced counterparts, suggesting that endogenous apelin and Aplnr also contributed to myocardial repair under normal conditions. Concordantly, in Aplnr knockdown animals, apelin treatment did not change epicardial infarct length or infarct thickness ( Figure 6C and 6D) , indicating that the remodeling effects of apelin requires Aplnrϩ BM cells. Infarct measurements using Evans blue dye supported these findings. Apelin recruitment of Aplnrϩ cells resulted in a reduction in infarct area compared with sh.sham virustreated controls ( Figure 6F) . In contrast, animals in which Aplnr was silenced in the BM proved to have an increase of infarct area as compared with their sham-silenced counterparts ( Figure 6F ).
Taken together, these findings suggest that apelin-recruited Aplnrϩ cells diminish myocardial scar formation early after MI, subsequently resulting in a persistent improvement of myocardial function.
Apelin-Recruited Aplnr؉ Cells Increase Neovascularization After Myocardial Ischemia
Apelin recruitment of cKitϩ/Flk1ϩ/Aplnrϩ cells increased capillary density in the infarct borderzone by 21%, compared with saline-treated animals in the sh.sham virus-treated mice ( Figure 7A through 7C) . In contrast, capillary densities in Aplnr-silenced groups were reduced by 9%, compared with the sham-silenced groups. Again, apelin treatment did not alter myocardial capillary density in Aplnr-silenced animals ( Figure 7C ). No effect on arteriolar density was observed between the experimental groups (Online Figure V) .
Aplnr؉ Cells Release Proangiogenic Cytokines
Although transgenic EGFPϩ BM-derived cells were abundant in the peri-infarct zone after MI in the control groups with and without apelin treatment, immunohistological analysis using CD31 to identify the vasculature showed negligible numbers of EGFPϩ incorporated in the neocapillaries (data not shown). We further hypothesized that recruited cKitϩ/ Flk1ϩ cells may have a paracrine proangiogenic effect, rather than provide cardioprotection by active transdifferentiation into neovasculature. Therefore, the cytokine profile of heart samples were assed 6 days after MI. Treatment with apelin resulted in an upregulation of VEGFA protein expression compared with saline-treated animals ( Figure 8A ). In line with these observations, VEGFA in Aplnr-silenced recipients of Aplnr-silenced BM was significantly downregulated compared with sham-silenced animals ( Figure 8A) , indicating that recruitment of BM-derived cells by Aplnr/apelin interaction was responsible for the observed increase in local VEGFA levels. In addition, angiopoietin-2 (Ang-2) levels relative to Ang-1 levels (Ang-2/Ang-1 ratio) in apelin-treated animals were increased compared with the sh.sham-treated animals ( Figure 8B through 8D). Myocardial Ang-2/Ang-1 ratio was markedly decreased in Aplnr-silenced animals ( Figure 8B through 8D) , suggestive of an antiangiogenic milieu. Aplnr-silenced animals were not responsive to apelin treatment and did not show a change in protein levels of any of these angiotrophic cytokines.
To assess if cKitϩ/Flk1ϩ/Aplnrϩ cells were indeed capable of producing these growth factors, sham-operated and MI animals were euthanized 5 days after surgery, and these cells were isolated from the heart using a flow cytometric cell sorter. Analysis of the mRNA expression showed that after MI these cells enhanced the expression of VEGFA and Ang-2, as compared with sham-operated animals ( Figure 8F  and 8G ). Ang-1 expression in these cells was diminished after MI as compared with sham-operated animals ( Figure 8E ).
Moreover, mRNA expression levels of other known angiogenic and cardioprotective factors were also enhanced after MI (Online Figure VI) . Interestingly, when cells isolated after MI were added to human umbilical vein endothelial cells (HUVECs) in an in vitro tube formation assay, an improvement in tube formation was observed (Online Figure VII) . Taken together, these data point toward a role for Aplnr/ apelin recruited BM-derived cells in providing a proangiogenic environment in affected heart areas after MI.
Discussion
In the current study, we have demonstrated that apelinrecruited Aplnrϩ cells improve cardiac neovascularization and improve remodeling and cardiac function after MI. Apelin was specifically upregulated in the myocardium and circulation during the first days after MI but not after HLI, resulting in the recruitment of cKitϩ/Flk1ϩ/Aplnrϩ cells to the circulation and the ischemic heart. Apelin induced recruit- whereas apelin failed to reduce myocardial scar formation in these animals (B). C and D, Quantification of infarct dimensions: infarct thickness (C) and epicardial infarct length (D) (nϭ7 per group). Myocyte cross-sectional area (CSA) did not differ between animals (E) (nϭ7 per group). *PϽ0.05 versus sh.sham saline and control. #PϽ0.05 versus corresponding sh.sham. F, Infarct sizes determined using Evans blue infusion 2 weeks after MI induction. Infarct sizes were reduced in apelin-treated sh.sham animals. Aplnrsilenced animals showed enhanced infarct sizes, and apelin injection had no effect in these animals (nϭ5 per group). *PϽ0.05 versus sh.sham saline and control. #PϽ0.05 versus corresponding sh.sham. ment of this specific subpopulation resulted in an increase in proangiogenic factors at 6 days after MI and subsequently the capillary density, resulting in diminished cardiac scar formation with sustained cardiac function. Silencing of Aplnr in the BM abolished the recruitment of this population after MI, leading to a failure to mount a neovasculogenesis response, resulting in marked loss of cardiac function and enhanced scarring. These data demonstrate the important role of apelin and Aplnrϩ cells in the orchestration of the myocardiumspecific ischemic repair response.
Given the marked expression of Aplnr and its ligand apelin in angioblasts during mammalian embryonic development and the expression of apelin after hypoxia, we hypothesized that Aplnr/apelin signaling plays a central role in ischemiadriven neovascularization. Aplnr is highly expressed in the circulating cKitϩ/Flk1ϩ subpopulation. The ligand apelin was significantly upregulated particularly early after MI. 36 Interestingly, this was not observed after HLI, suggesting that Aplnr/apelin signaling plays a specific role in a myocardium repair response.
Also cKitϩ/Flk1ϩ/Aplnrϩ cell numbers were increased in the circulation in response to myocardial ischemia but not in response to hind limb ischemia. In contrast, Sca1ϩ/Flk1ϩ cells were recruited after HLI but failed to be recruited after MI. These data suggest a specific cell response for MI versus HLI. After a single intramyocardial injection, apelin induced an accelerated mobilization and homing of the cKitϩ/Flk1ϩ/ Aplnrϩ cells not only into the myocardium but also in to striated muscles after a local injection of apelin into the ischemic hind limb. In contrast, cells with a lower Aplnr expression, like the Sca1ϩ/Flkϩ and Linϩ cells, failed to respond to apelin. These cells, however, showed a response to an injection of known chemotactic factors VEGFA or SDF␣, whereas this was not the case for cKitϩ/Flk1ϩ cells, suggesting separate but additive recruitment pathways. These data further underline the remarkably potent but specific chemoattractive function of apelin, even in tissue in which its expression is normally not enhanced in response to ischemia.
Recruitment of cKitϩ/Flk1ϩ/Aplnrϩ cells by apelin promotes local neoangiogenesis resulting in preserved cardiac function and diminished adverse remodeling with reduced scar formation after MI. The importance of cell recruitment was earlier suggested in animals with impaired cKit function. 7 In these animals, recruitment of cells after MI was diminished and resulted in pronounced scar formation with poor residual cardiac function.
Interestingly, recruited cells did not differentiate into endothelial cells. This suggests that these cKitϩ/Flk1ϩ/ Aplnrϩ cells may express proangiogenic factors and locally stimulate resident ECs to initiate angiogenesis, consistent with earlier findings. 37, 38 In Aplnr-silenced hybrid mice, cKitϩ/Flk1ϩ cell recruitment was severely impaired after MI, resulting in diminished neovascularization and pronounced scar formation with poor residual cardiac function after MI. The recruitment of Scaϩ/Flkϩ and Linϩ cells was not effected after Aplnr silencing, suggesting that apelin signaling does not play a crucial role in the mobilization of these cells. Importantly, apelin treatment in animals with Aplnr-silenced expression in BM cells failed to enhance the recruitment of the cKitϩ/Flk1ϩ cell population; nor did it change capillary density, suggesting that the beneficial effect is mainly mediated by recruitment of BM derived cells and not a local effect on residential cells.
Increased recruitment of cKitϩ/Flk1ϩ/Aplnrϩ cells by apelin injection was associated with an increase in local VEGFA expression and Ang-2/ Ang-1 ratio, whereas loss of Aplnr in the BM was associated with a decreased VEGFA expression and Ang-2/Ang-1 ratio. Ang-2 has been shown to block the quiescent signal of Ang-1 and to enhance the sensitivity of endothelial cells to VEGFA. 39, 40 Isolated cKitϩ/Flk1ϩ/Aplnrϩ cells proved to have an enhanced expression of VEGFA and Ang-2 and a reduced expression of Ang-1 after MI, indicating that they are at least in part responsible for the production of these cytokines. In line with our observations, another study showed that a mutation in the cKit gene, resulting in a dysfunctional protein, was associated with the reduced recruitment of cKitϩ cells into the ischemic myocardium. 7 This reduced recruitment resulted in a local decrease in VEGFA and Ang-2 production, suggesting a role of these cells in the release of the angiotrophic factors. A, VEGFA protein expression in the myocardium was increased in apelin-treated sham-silenced mice. Aplnr-silenced animals showed reduced VEGFA protein expression, as compared with sham virus-treated animals. Apelin treatment did not result in an increase of VEGFA protein in these animals. (nϭ5 per group). B and C, Myocardial expression of Ang-1 and Ang-2. D, Apelin treatment in sham-silenced mice increased Ang-2/Ang-1 ratio, whereas Aplnr-silenced animals showed inverse effects (nϭ5 per group). *PϽ0.05 versus sham saline. E through G, mRNA expression in isolated cKitϩ/Flk1ϩ/Aplnrϩ cells after MI. CKitϩ/Flk1ϩ/Aplnrϩ cells enhanced their mRNA expression of VEGFA (G) and Ang-2 (F) after MI, as compared with cKitϩ/Flk1ϩ/Aplnrϩ isolated from sham-operated hearts. The mRNA expression of Ang-1 (E) was decreased in these cells after MI as compared with cKitϩ/Flk1ϩ/Aplnrϩ isolated from sham-operated hearts (nϭ3 for each group). *PϽ0.05 versus sham.
We also observed an enhanced mRNA expression of other known angiogenic and cardioprotective factors in these isolated cells after MI, 41 indicating other protective mechanisms.
In vitro experiments to study if cKitϩ/Flk1ϩ/Aplnrϩ cells could directly affect angiogenesis again indicated a stimulating effect of these cells. When HUVECs were cultured in combination with these cells in an in vitro tube formation assay, we observed an increase in the number of tubes and junction formed. These observations proved that cKitϩ/ Flk1ϩ/Aplnrϩ can directly stimulate local angiogenesis.
Our data indicate a central role of Aplnr and apelin interaction in myocardial repair response to ischemia, by attracting a specific subset of cells toward the myocardium. Indeed, apelin expression is reduced in diabetes and hypercholesterolemia, 42,43 2 known risk factors that have been associated with low circulating proangiogenic cell numbers with impaired function, resulting in an attenuated neoangiogenesis response. 44, 45 Moreover, physical exercise has been shown to promote the neoangiogenesis response by recruitment of circulating cells 46 and has also been associated with increased apelin levels. 47 In summary, the current study provides evidence for a central role of Aplnr/apelin interaction in the recruitment of cKitϩ/Flk1ϩ/Aplnrϩ cells toward the myocardium in the early phase after MI, where these cells enhance the local release of proangiogenic cytokines to promote neovascularization and limit myocardial damage and cardiac dysfunction. It is even possible that some growth factors produced by recruited cKitϩ/Flk1ϩ/Aplnrϩ cells mobilize and recruit other cell subset that repair the myocardium. To evaluate this interesting concept of possible interactions and dependence between subsets of cells in the MI condition, further research is needed. Other mediators, such as VEGFA, GM-CSF, SDF-1, and Ang-1 have been proven to enhance the number of circulating cells and neovascularization after ischemia, 10 -13 but to our knowledge, none of these pathways is specific for the myocardial repair response. The apelin/Aplnr pathway may therefore represent a unique repair mechanism that may represent a new therapeutic approach to limit myocardial damage and dysfunction after MI. 
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